Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03870165 · ClinicalTrials.gov registry record · NA

Food First Approach to Stimulate Muscle Protein Synthesis in Healthy Adults

A NA study, sponsored by University of Illinois at Urbana-Champaign.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT03870165: Completed NA study, sponsored by University of Illinois at Urbana-Champaign.

NCT03870165 is a NA study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03870165, a NA study, has completed, sponsored by University of Illinois at Urbana-Champaign.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

In a crossover design 10 young healthy adults (20-35 y) will receive stable isotope tracer infusions and perform a single bout of resistance exercise. Immediately after exercise participants will ingest either 3.5 oz of Salmon fillet or its constituent macronutrients as isolated amino acids and fat. Repeated blood and breath samples as well as muscle biopsies will be collected to determine whole body amino acid kinetics, muscle amino acid transporters, anabolic signalling and myofibrillar protein synthesis rates during the trials

Primary Outcome

Myofibrillar protein synthesis rates will be assessed during the postabsorptive period for 3 hr and during the 5 hr after the ingestion of the experimental interventions. This will allow us to assess the change from the postabsorptive to the postprandial period.

Interventions

  • BEHAVIORAL Resistance exercise
  • OTHER Salmon
  • DIETARY_SUPPLEMENT Isolated amino acids and fatty acids

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2019-03-01
Est. Completion 2019-11-22
Phase NA

What the finished NCT03870165 record still lists

NCT03870165 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 3 interventions - of which Resistance exercise is the first listed.

NCT03870165 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03870165 about?

NCT03870165 is a clinical study titled "Food First Approach to Stimulate Muscle Protein Synthesis in Healthy Adults". In a crossover design 10 young healthy adults (20-35 y) will receive stable isotope tracer infusions and perform a single bout of resistance exercise. Immediately after exercise participants will ingest either 3.5 oz of Salmon fillet or its constituent macronutrients as isolated amino acids and fat....

What is the current status of trial NCT03870165?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-03-01. Estimated completion is 2019-11-22.

What interventions are being tested in trial NCT03870165?

The interventions under investigation include: Resistance exercise (BEHAVIORAL), Salmon (OTHER), Isolated amino acids and fatty acids (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03870165?

This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03870165's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03870165, the US trial registry maintained by the National Library of Medicine. NCT03870165 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.